Lucid Diagnostics (LUCD) EBT Margin (2021 - 2026)
Lucid Diagnostics' (LUCD) quarterly EBT Margin came in at 1069.92% in Q1 2026, up 217984.0% YoY from N/an in Q1 2025, and up 1.47% on a QoQ basis from 1085.85% in Q4 2025.
Lucid Diagnostics (LUCD) EBT Margin (2021 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 6 years of EBT Margin data on file, last reported at 1069.92% in Q1 2026.
- Quarterly EBT Margin rose 217984.0% year-over-year to 1069.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 864.1% (up 61745.0% YoY) and the FY2025 annual result came in at 1234.26%, down 18665.0% from the prior year.
- EBT Margin climbed to 1069.92% in Q1 2026, from 1085.85% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 369.92% in Q2 2025 to a low of 18880.26% in Q3 2022.
- A 5-year average of 3949.93% and a median of 1106.7% in 2025 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin sank 1540176 bps — and 2023, when it soared 1706570 bps.
- Tracing LUCD's EBT Margin over 5 years: stood at 13328.57% in 2022, then soared by 92 bps to 1041.35% in 2023, then gained by 7 bps to 964.16% in 2024, then retreated by 13 bps to 1085.85% in 2025, then rose by 1 bps to 1069.92% in 2026.
- The last three EBT Margin figures came in at 1069.92% (Q1 2026), 1085.85% (Q4 2025), and 858.55% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.32% |
| 10 | Lucid Diagnostics | 176.81 Mn | 143.40 Mn | 55,000.00 | -779.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -779.13% |
| Mar 31, 2026 | -1,069.92% |
| Dec 31, 2025 | -1,085.85% |
| Sep 30, 2025 | -858.55% |
| Jun 30, 2025 | -369.92% |
| Mar 31, 2025 | -3,249.76% |
| Dec 31, 2024 | -964.16% |
| Sep 30, 2024 | -1,055.55% |
| Jun 30, 2024 | -1,127.56% |
| Mar 31, 2024 | -1,060.14% |
| Dec 31, 2023 | -1,041.35% |
| Sep 30, 2023 | -1,814.56% |
| Jun 30, 2023 | -7,157.86% |
| Mar 31, 2023 | -3,642.83% |
| Dec 31, 2022 | -13,328.57% |
| Sep 30, 2022 | -18,880.26% |
| Mar 31, 2022 | -6,492.06% |
| Dec 31, 2021 | -3,768.67% |
| Sep 30, 2021 | -3,478.50% |